Participant recruitment
Melanoma, melanoma
MELANOMA, MELANOMA, RECRUITMENT, METASTATIC CANCER, EVENTS
Melanoma patients receiving checkpoint inhibitor therapy were identified by attending oncology services at Sir Charles Gairdner Hospital, Fiona Stanley Hospital, and Hollywood Private Hospital, who provided them with a recruitment flyer containing information about the study. Flyers were also distributed through online melanoma support groups and at community events. Participants were screened to ensure they met the inclusion criteria: 18 years or older, diagnosed with stage III‐IV melanoma and receiving or about to receive checkpoint inhibitor therapy. Participants were excluded if they: (i) had an acute illness or musculoskeletal, cardiovascular or neurological disorder that could inhibit exercise participation; (ii) had an uncontrolled medical condition (other than metastatic cancer); and (iii) presented with a cardiovascular or pulmonary contraindication to exercise listed in the American College of Sports Medicine (ACSM) guidelines.